Conference Coverage: EHA Congress 2012
News
Early BCR-ABL Predicts Survival in Nilotinib-Treated CML
Major Finding: In the nilotinib-treated group, 96.9% of those who achieved BCR-ABL transcript levels of 1% or less and 98.8% of those who achieved...
Conference Coverage
CNS Events Not Immediately Fatal in Mantle Cell Lymphomas
Major Finding: Crude prevalences of CNS involvement at diagnosis and overall were 0.9% and 4.1%, respectively, with a median time to an event of...
News
Elderly Lymphoma Patients Might Be Spared Radiotherapy
Major Finding: After multivariate adjustment, 3-year EFS, PFS, and OS were no different in patients who had received radiotherapy for bulky...
News
Evidence Mounts for Crizotinib Efficacy in ALK-Positive Lymphoma
Major Finding: Eight of nine patients responded to crizotinib, and four had durable responses lasting more than 6 months.Data Source: Nine adults...